Becton, Dickinson and (BDX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Becton, Dickinson and Revenue Highlights

Latest Revenue (Y)

$20.18B

Latest Revenue (Q)

$4.99B

Main Segment (Y)

Medical

Main Geography (Y)

UNITED STATES

Becton, Dickinson and Revenue by Period

Becton, Dickinson and Revenue by Year

Date	Revenue	Change
2024-09-30	$20.18B	4.16%
2023-09-30	$19.37B	2.66%
2022-09-30	$18.87B	-6.81%
2021-09-30	$20.25B	18.29%
2020-09-30	$17.12B	-1.00%
2019-09-30	$17.29B	8.18%
2018-09-30	$15.98B	32.17%
2017-09-30	$12.09B	-3.12%
2016-09-30	$12.48B	21.41%
2015-09-30	$10.28B	21.74%
2014-09-30	$8.45B	4.87%
2013-09-30	$8.05B	4.48%
2012-09-30	$7.71B	-1.54%
2011-09-30	$7.83B	6.19%
2010-09-30	$7.37B	2.95%
2009-09-30	$7.16B	0.07%
2008-09-30	$7.16B	12.52%
2007-09-30	$6.36B	9.00%
2006-09-30	$5.83B	7.76%
2005-09-30	$5.41B	9.73%
2004-09-30	$4.93B	8.98%
2003-09-30	$4.53B	12.27%
2002-09-30	$4.03B	7.43%
2001-09-30	$3.75B	3.76%
2000-09-30	$3.62B	5.85%
1999-09-30	$3.42B	9.67%
1998-09-30	$3.12B	10.90%
1997-09-30	$2.81B	1.47%
1996-09-30	$2.77B	2.11%
1995-09-30	$2.71B	5.98%
1994-09-30	$2.56B	3.82%
1993-09-30	$2.47B	-

Becton, Dickinson and generated $20.18B in revenue during NA 2024, up 4.16% compared to the previous quarter, and up 116.70% compared to the same period a year ago.

Becton, Dickinson and Revenue by Quarter

Date	Revenue	Change
2024-06-30	$4.99B	-1.09%
2024-03-31	$5.04B	7.20%
2023-12-31	$4.71B	-7.49%
2023-09-30	$5.09B	4.28%
2023-06-30	$4.88B	1.18%
2023-03-31	$4.82B	5.12%
2022-12-31	$4.59B	-3.68%
2022-09-30	$4.76B	2.59%
2022-06-30	$4.64B	-7.38%
2022-03-31	$5.01B	6.21%
2021-12-31	$4.72B	-8.12%
2021-09-30	$5.13B	5.01%
2021-06-30	$4.89B	-0.35%
2021-03-31	$4.91B	-7.68%
2020-12-31	$5.32B	11.10%
2020-09-30	$4.78B	24.10%
2020-06-30	$3.85B	-9.36%
2020-03-31	$4.25B	0.66%
2019-12-31	$4.22B	-7.83%
2019-09-30	$4.58B	5.38%
2019-06-30	$4.35B	3.69%
2019-03-31	$4.20B	0.84%
2018-12-31	$4.16B	-5.50%
2018-09-30	$4.40B	2.90%
2018-06-30	$4.28B	1.33%
2018-03-31	$4.22B	37.08%
2017-12-31	$3.08B	-2.72%
2017-09-30	$3.17B	4.32%
2017-06-30	$3.04B	2.22%
2017-03-31	$2.97B	1.61%
2016-12-31	$2.92B	-9.56%
2016-09-30	$3.23B	1.03%
2016-06-30	$3.20B	4.27%
2016-03-31	$3.07B	2.71%
2015-12-31	$2.99B	-2.42%
2015-09-30	$3.06B	-1.92%
2015-06-30	$3.12B	52.12%
2015-03-31	$2.05B	-
2014-12-31	$2.05B	-6.86%
2014-09-30	$2.20B	2.09%
2014-06-30	$2.16B	4.10%
2014-03-31	$2.07B	2.83%
2013-12-31	$2.02B	-4.08%
2013-09-30	$2.10B	2.34%
2013-06-30	$2.05B	2.61%
2013-03-31	$2.00B	5.27%
2012-12-31	$1.90B	-3.40%
2012-09-30	$1.97B	-0.67%
2012-06-30	$1.98B	-0.52%
2012-03-31	$1.99B	5.47%
2011-12-31	$1.89B	-7.96%
2011-09-30	$2.05B	1.82%
2011-06-30	$2.01B	4.79%
2011-03-31	$1.92B	4.34%
2010-12-31	$1.84B	6.32%
2010-09-30	$1.73B	-7.76%
2010-06-30	$1.88B	1.81%
2010-03-31	$1.84B	-3.75%
2009-12-31	$1.92B	1.00%
2009-09-30	$1.90B	4.26%
2009-06-30	$1.82B	4.56%
2009-03-31	$1.74B	0.42%
2008-12-31	$1.73B	-5.56%
2008-09-30	$1.84B	-1.71%
2008-06-30	$1.87B	6.91%
2008-03-31	$1.75B	-

Becton, Dickinson and generated $4.99B in revenue during Q3 2024, up -1.09% compared to the previous quarter, and up 103.51% compared to the same period a year ago.

Becton, Dickinson and Revenue Breakdown

Becton, Dickinson and Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Interventional	$4.98B	-	-	-	-
Medical	$10.07B	$2.00B	-	-	-
Life Sciences	$5.19B	$2.30B	-	-	-
Consumables	-	$2.00B	$1.90B	$2.50B	$2.60B
Products and/or Services	-	$2.30B	$2.50B	$2.10B	$1.90B

Becton, Dickinson and's latest annual revenue breakdown by segment (product or service), as of Sep 24: Medical (49.76%), Life Sciences (25.64%), and Interventional (24.60%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Interventional	$4.04B	$489.00M	$454.00M	$318.00M	$306.00M	$293.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Life Sciences	$299.00M	$2.30B	$1.30B	$1.29B	$930.00M	$1.18B	$377.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Medical	$5.82B	$2.10B	$1.11B	$1.05B	$581.00M	$552.00M	$486.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Consumables	-	-	-	$2.20B	-	$2.10B	$2.20B	$1.90B	$2.10B	$2.40B	$2.40B	$2.80B	$2.70B	$2.60B	$2.60B	$2.70B	$2.70B	-	-	-
Products and/or Services	-	-	-	$2.20B	-	$2.50B	$2.50B	$2.50B	$2.20B	$2.20B	$2.10B	$1.90B	$1.90B	$1.90B	$1.60B	$1.70B	$1.80B	-	-	-

Becton, Dickinson and's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Medical (57.28%), Interventional (39.77%), and Life Sciences (2.95%).

Becton, Dickinson and Revenue Breakdown by Country

Annual Revenue by Country

Country	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Europe	$4.40B	$4.24B	$3.48B	-	-
Asia	$2.91B	$2.91B	$3.05B	$3.27B	$2.57B
UNITED STATES	$11.66B	$11.11B	$10.72B	$10.97B	$9.72B
Others Country	$1.21B	$1.10B	$1.06B	$1.25B	$1.35B
EMEA	-	$4.24B	$4.04B	$4.75B	-

Becton, Dickinson and's latest annual revenue breakdown by geography, as of Sep 24: UNITED STATES (57.80%), Europe (21.82%), Asia (14.40%), and Others Country (5.98%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
UNITED STATES	$3.12B	$2.89B	$2.91B	$2.75B	$2.88B	$2.77B	$2.73B	$2.73B	$2.71B	$2.64B	$2.81B	$2.85B	$2.80B	$2.57B	$2.46B	$3.13B	$2.75B	$2.12B	$2.42B	$2.43B
Non-US	-	$2.10B	$2.14B	$1.96B	$2.21B	$2.11B	$2.09B	$1.86B	$2.05B	$2.00B	$2.20B	$2.14B	$2.33B	$2.32B	$2.45B	$2.19B	$2.03B	$1.74B	$1.84B	$1.79B

Becton, Dickinson and's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (100.00%).

Becton, Dickinson and Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BDX	Becton, Dickinson and	$20.18B	$4.99B
ALC	Alcon	$10.09B	$2.46B
RMD	ResMed	$4.69B	$1.22B
HOLX	Hologic	$4.03B	$1.01B
XRAY	DENTSPLY SIRONA	$3.96B	$951.00M
COO	Cooper Companies	$3.90B	$1.00B
TFX	Teleflex	$2.97B	$764.38M
WST	West Pharmaceutical Services	$2.95B	$746.90M
ICUI	ICU Medical	$2.26B	$589.13M
HAE	Haemonetics	$1.31B	$336.17M
RGEN	Repligen	$638.76M	$141.19M
ANGO	AngioDynamics	$303.91M	$72.84M

BDX Revenue FAQ

What is Becton, Dickinson and’s yearly revenue?

Becton, Dickinson and's yearly revenue for 2024 was $20.18B, representing an increase of 4.16% compared to 2023. The company's yearly revenue for 2023 was $19.37B, representing an increase of 2.66% compared to 2022. BDX's yearly revenue for 2022 was $18.87B, representing a decrease of -6.81% compared to 2021.

What is Becton, Dickinson and’s quarterly revenue?

Becton, Dickinson and's quarterly revenue for Q3 2024 was $4.99B, a -1.09% decrease from the previous quarter (Q2 2024), and a 2.30% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $5.04B, a 7.20% increase from the previous quarter (Q1 2024), and a 4.65% increase year-over-year (Q2 2023). BDX's quarterly revenue for Q1 2024 was $4.71B, a -7.49% decrease from the previous quarter (Q4 2023), and a 2.62% increase year-over-year (Q1 2023).

What is Becton, Dickinson and’s revenue growth rate?

Becton, Dickinson and's revenue growth rate for the last 3 years (2022-2024) was 6.93%, and for the last 5 years (2020-2024) was 17.88%.

What are Becton, Dickinson and’s revenue streams?

Becton, Dickinson and's revenue streams in p 24 are Interventional, Medical, and Life Sciences. Interventional generated $4.98B in revenue, accounting 24.60% of the company's total revenue Medical generated $10.07B in revenue, accounting 49.76% of the company's total revenue, up 403.70% year-over-year. Life Sciences generated $5.19B in revenue, accounting 25.64% of the company's total revenue, up 125.70% year-over-year.

What is Becton, Dickinson and’s main source of revenue?

For the fiscal year ending Sep 24, the largest source of revenue of Becton, Dickinson and was Medical. This segment made a revenue of $10.07B, representing 49.76% of the company's total revenue.